Individuals with Parkinson disease (PD) have balance impairments and postural instability. This leads to an increased risk of falling and an increase in both fractures and soft tissue injury.1–5 Decreased postural stability is also associated with decreased quality of life,6 and individuals with PD tend to limit their activity levels because of a fear of falling, contributing to inactivity and further compromising balance.2,4,7 Some studies have shown that more than 60% of individuals with PD fall at least once in a 12-month period.8,9 Because of the negative impact of balance impairments on individuals with PD, it is important to be able to assess who has a balance deficit and is at increased risk of falling. Identification of those at risk is essential to intervene, as physical therapy and exercise have been shown to improve balance.10 Currently, many different balance outcome measures and fall risk assessments are being used in individuals with PD.11–15 Many of these measures have limitations including low sensitivity and/or specificity,11,16 ceiling effects,17,18 and inclusion of items that physical therapy intervention cannot address (such as prior number of falls).14,19,20 Some research has shown that a battery of tests is necessary to fully assess balance; however, a consensus on which tests to include and interpretation of results from multiple tests has not been reached.12,16,21
Balance is a complex construct with many contributing physiological systems. To help differentiate between possible causes of imbalance, the Balance Evaluation Systems Test (BESTest) was developed.22 The BESTest is a balance assessment for mixed populations that includes 36 items divided into 6 sections, each of which is designed to test a theoretical control system for balance: Section I—Biomechanical Constraints, Section II—Stability Limits and Verticality, Section III—Anticipatory Postural Adjustments, Section IV—Postural Responses, Section V—Sensory Orientation, and Section VI—Stability in Gait.22 Although there is some overlap between the sections, ideally the scores across sections allow a physical therapist to choose treatments that will focus on the primary deficits causing the balance impairment. Each section has also been proposed to be used separately if needed.22
The BESTest total score has been shown to have high interrater reliability and moderate concurrent validity with an individual's self-perceived balance in a mixed population including individuals with PD, vestibular dysfunction, hip arthroplasty, peripheral neuropathy, and healthy controls.22 In this mixed population, each section of the BESTest had high interrater reliability. Another study showed that the BESTest is a valid measure of balance for individuals with PD, having high correlations with the Berg Balance Scale, disease severity, and the Activities Specific Balance Confidence Scale. The BESTest was more sensitive and specific at identifying who was a faller and a nonfaller, more accurate overall at discriminating a faller, and had more useful posttest probabilities than the Berg Balance Scale.23
The length of BESTest, taking 30 to 35 minutes to perform, decreases its clinical utility and feasibility. To address the limitations associated with this lengthy time requirement, and to improve the psychometric properties and unidimensional structure of the BESTest, the Mini-BESTest was developed. The Mini-BESTest is a shortened version that includes only 16 of the original 36 BESTest items, is believed to measure dynamic balance, and takes only 10 to 15 minutes to perform.24 Dynamic balance is a balance that is associated with movement during transfers and gait, as well as external perturbations and cognitive dual-task performance.
This study aimed to the compare the discriminative capability of the Mini-BESTest to the BESTest, as well as determine the reliability and utility of the Mini-BESTest, and of each section of the BESTest in individuals with PD. We hypothesized that the Mini-BESTest would be reliable and perform comparably to the BESTest in identifying fallers. We also hypothesized that individuals with PD might have lower scores on Section I—Biomechanical Constraints and Section IV—Postural Responses compared with other sections of the BESTest. The reliability and discriminative properties of the full BESTest have been presented elsewhere.23 This study further explored the reliability of each section of the full BESTest and compared scores between fallers and nonfallers for each section.
Eighty individuals with PD completed the study, with fallers defined as those who had 2 or more self-reported falls in the previous 6 months. Participants were recruited using a database from the Washington University in St. Louis Movement Disorders Center database. Individuals were called, using a random number generator, from a stratified list based on Hoehn and Yahr (H&Y)26 stagingto ensure that participants across stages of disease severity were recruited. Inclusion criteria included a diagnosis of idiopathic PD, older than 40 years, H&Y stages I to IV, community-dwelling, and the ability to follow commands and give informed consent. Exclusion criteria included a diagnosis of atypical PD and a prior surgical treatment of PD. Individuals from the St. Louis area who heard about the study from other participants or through the Volunteers for Health database also participated. Eighty-two individuals met the inclusion criteria and were tested; however, 2 participants were unable to complete the study because of unrelated illness or exclusion criteria. The study was approved by the Human Research Protection Office, and all participants provided informed consent before participating.
Evaluations were performed at Washington University in St. Louis in a laboratory setting. Participants provided demographic and recent fall information. Disease severity was measured using the Movement Disorders Society Unified Parkinson Disease Rating Scale (MDS-UPDRS) and modified H&Y staging.25,26 The BESTest with slight modifications and Mini-BESTest were performed along with a larger battery of balance and gait tests that took a total of 2 hours. The full battery included the Berg Balance Scale, Functional Gait Assessment, 6-minute walk test, and 10-m walk test, as well as a series of questionnaires. Fall status was assessed via questionnaire, so raters were blinded to fall status until after completion of testing. No specific definition of a fall was described. Participants were tested on medication, as they were instructed to take their medication according to their normal regimen.
The full, 36-item BESTest with slight modifications was administered with shoes off, unless discomfort was expressed by the participant. The balance test is scored using a 4-point scale, 0 to 3, with a higher score indicating better balance. The maximum score for the full BESTest is 108. All sections of the test were performed as described by Horak et al,22 except slight alterations in sections IV and V. In section IV items 16 to 18, 2 trials were performed, with the second trial always being rated. This was to allow consistency, as many individuals would not lean appropriately beyond their stability limits into the tester's hands during the first trial to adequately assess compensatory stepping. In section V, only 1 trial was used for each item because of time constraints. During item 27, the dual-task Timed Up and Go, option b (listing random numbers) was always used. The score for each section and the total BESTest score were converted into percentage scores, as is designated in the BESTest instructions.22
The Mini-BESTest is rated on a 3-point scale from 0 to 2. A perfect score is 32. The final score was reported in both crude score and a percentage score for comparison with the BESTest. Although all items of the Mini-BESTest are included in the BESTest, the grading criteria are different. During the performance of the full BESTest, the items were graded according to the criteria for both the BESTest and the Mini-BESTest so that no items had to be repeated.
Interrater reliability of each section of the BESTest and the Mini-BESTest was determined using a subgroup of participants (n = 15: MDS-UPDRS = 74.2 ± SD 18.6, disease duration = 6.8 ± SD 3.26; H&Y stage 1 had 2 participants, stage 2 had 7 participants, stage 2.5 had 3 participants, stage 3 had 2 participants, stage 4 had 1 participant; 20% (n = 3) were fallers with fallers at H&Y stages 2.5, 3, and 4). Scoring was performed by 3 raters (2 physical therapists and 1 student physical therapist); the physical therapists had 13 and 21 years of experience, and the student had finished 2 years of a doctorate of physical therapy program. All raters watched the BESTest training video (available for purchase online)27 and read the testing procedures. The raters had one training trial, testing one individual without PD before testing participants. The purpose of this trial was to familiarize raters with the order in which the items would be presented. All raters concurrently scored each evaluation, while one of the raters (author A.L.) administered the test. If an item was missed by any rater, the item was repeated and all raters scored the second trial. Scoring was not discussed.
Test-retest reliability was determined using a subgroup of study participants (n = 24: MDS-UPDRS = 71 ± SD 21.9, disease duration = 6.9 ± SD 3.38; H&Y stage 1 had 2 participants, stage 2 had 11 participants, stage 2.5 had 6 participants, stage 3 had 3 participants, and stage 4 had 2 participants; 21% [n = 5] were fallers with fallers at H&Y stages 2.5, 3, 3, 4, and 4). Participants were evaluated twice, with 2 weeks between evaluations (range = 11-16 days). Testing was performed on medication at the same time of the day for both test sessions to prevent possible balance fluctuations due to medication. After the initial 24 participants were tested and the reliability was determined to be acceptable, the student physical therapist (author A.L.) continued administering the evaluation for the remainder of the participants to reach a total of 80 participants.
Statistics were calculated using SPSS for Windows (version 17.0, SPSS Inc, Chicago, Illinois). The distributions of scores were assessed using the Kolmogorov-Smirnov (K-S) test. Independent sample t tests were used for comparisons between fallers and nonfallers for age, MDS-UPDRS total score, duration of disease, total BESTest score, and Mini-BESTest scores. Mann-Whitney U tests were used for H&Y staging and for each section of the BESTest. Bonferroni correction was used for multiple comparisons, with P < 0.00625 being statistically significant for comparisons between fallers and nonfallers in the balance testing and P < 0.0125 for demographic and disease severity information. Pearson's rank correlation coefficient was used to examinethe relationship between the Mini-BESTest to the BESTest total score. Although the grading scale is ordinal for both the BESTest and the Mini-BESTest, we considered the score of each section of the BESTest and the total score of the BESTest and Mini-BESTest to be continuous data. Intraclass correlations (ICC 2,1), 2-way random, absolute agreement were used to assess both interrater and test-retest reliability of the BESTest sections and the Mini-BESTest.
A receiver operating characteristic plot was used to compare overall accuracy of the BESTest with that of the Mini-BESTest, as well as to determine appropriate cutoff scores for identifying a faller versus a nonfaller. Cutoff scores were reported using 2 methods. The first method maximized both sensitivity and specificity, compromising between avoiding false negatives and avoiding false positives. The second method maximized sensitivity and minimized the negative likelihood ratio (LR−) for being a faller, which selected the score most likely to identify as many fallers as possible without regard to increased false positives. A positive likelihood ratio (LR+) is the probability of someone who is a faller having a positive test divided by the probability of someone without the disease having a positive test (scoring below the cutoff score), and a LR− ratio is the probability of someone who is a faller having a negative test (scoring above the cutoff score) divided by the probability of someone without the disease having a negative test.28 Bayes Theorem was used to calculate posttest probabilities of being a faller. Bayes Theorem quantifies the odds of someone being a faller after performing the balance test by multiplying the pretest odds of being a faller by the likelihood ratio.29 These odds can then be converted into the percent chance of being a faller.
Sample size calculations were based on α = 0.05, with a power of 0.80. For reliability, a null ICC was 0.5, and an acceptable reliability was 0.8. For interrater reliability between 3 raters, a sample of 15 participants was required. For test-retest reliability using 2 test sessions, 22 participants were required. With an estimated fall rate of 30%, CI width of 0.20, and a 95% confidence interval, 81 participants were needed for sensitivity, specificity, and receiver operating characteristic plots.
Twenty-five of the 80 participants (31.3%) were fallers. Participants had an average age of 68.2 (SD = 9.3) years with an average H&Y score stage of 2.45 (SD 0.64) and UPDRS score of 72.6 (SD = 25.1). Disease duration, MDS-UPDRS score, and H&Y stage were all significantly different between fallers and nonfallers (P < 0.001), but age was not (P = 0.681). Demographic information for the overall sample, as well as the fallers and nonfallers separately, is presented in Table 1.
The Mini-BESTest scores were normally distributed (K-S, P = 0.16). There was a statistically significant difference between fallers and nonfallers, with an average difference of 27% between the groups (Table 1). Mini-BESTest had high interrater and test-retest reliability (ICC = 0.91 and 0.92, respectively) (Tables 2 and 3).
BESTest and Sections
The total BESTest scores were normally distributed (K-S, P = 0.47). When assessing individual sections of the BESTest, only sections IV and V were not normally distributed (K-S, P = 0.038 and P < 0.001, respectively) and had unequal variance between groups. Student t tests reported for these 2 sections are based on unequal variance assumptions. On average, the overall study sample scored lowest on section I (Biomechanical Constraints) at 59% and highest on section II (Stability Limits/Verticality) at 80%.
For the BESTest total score and all sections of the BESTest, there was a statistically significant difference between fallers and nonfallers (Table 1). Section II showed the least difference between fallers and nonfallers, with an average difference of only 9%. All other sections showed 17% to 24% difference in average scores between fallers and nonfallers, while the overall BESTest showed a 19% difference.
Interrater reliability was lowest for sections I and II with ICC = 0.81 and = 0.79, respectively. All other sections of the BESTest and the overall BESTest had high interrater reliability (ICC ≥ 0.86) (Table 2). Test-retest reliability varied between sections of the BESTest, but it was high for the overall BESTest (ICC = 0.88) (Table 3).
Correlation and Accuracy
The Mini-BESTest demonstrated a strong relationship with the BESTest total score (r = 0.955). The Mini-BESTest overall accuracy for identifying who was a faller was comparable to the BESTest, with an area under the curve of 0.86 (95% CI: 0.76-0.95) for the Mini-BESTest and 0.84 (95% CI: 0.75-0.93) for the BESTest.
When both sensitivity and specificity are maximized, a cutoff score of 20/32 (63%) was identified for the Mini-BESTest (sensitivity = 0.88, specificity = 0.78) and 69% was identified for the BESTest (sensitivity = 0.84, specificity = 0.76). When maximizing sensitivity and LR−, a cutoff score of 23/32 (72%) was identified for the Mini-BESTest (sensitivity = 0.96, specificity = 0.47) and 84% for the BESTest (sensitivity = 1.0, specificity = 0.39) (Figure 1 and Table 4).
This study expands upon previously reported data describing the reliability, validity, and discriminatory ability of the BESTest in individuals with PD.23 This previous work demonstrated that the BESTest was superior to the Berg Balance Scale in discriminating between fallers and nonfallers. The present work shows a significant difference between fallers and nonfallers for all individual sections of the BESTest, and perhaps more importantly, that the Mini-BESTest is a reliable measure of balance in individuals with PD. The Mini-BESTest is comparable with the BESTest in its ability to discriminate between fallers and nonfallers and is more feasible for clinical use than the full BESTest since it can be administered in a shorter time (estimated 15 and 35 minutes, respectively).
Individuals with PD scored lowest in section I (Biomechanical Constraints, 59%), as hypothesized, since postural abnormalities are known to be common in individuals with PD.3 Average scores were highest on section II (Verticality/Stability Limits, 80%), which is interesting as functional reach laterally and forward account for a over a third of this section and spinal flexibility is thought to be impaired in individuals with PD.30 The remaining items in section II, however, included leaning and midline orientation while in sitting, which might not be as affected in individuals with PD. Scores on sections III to VI ranged from 68% to 75%. The interrater reliability for each section was very similar to what was reported in a mixed population.22 Test-retest reliability was variable for the sections of the BESTest. This variability could be a result of the decreased heterogeneity of the smaller sections of the BESTest as well as the nonnormal distribution of sections IV and V, as ICC calculations inherently compare the measurement error to the total variability seen in the group.31
All sections of the BESTest were statistically different between fallers and nonfallers. There was not a specific section, or balance control system, that showed a more prominent change in those who are fallers. The fact that a specific section is not affected consistently could be due to the fact that there is overlap between the sections, and the 6 theoretical control systems have not been truly isolated. Alternatively, it may be that there are many underlying balance deficits that contribute to the increased risk for falling, including postural reflex, sensory, strength, motor control, postural adjustment, and attention allocation deficits in individuals with PD.3,9,32 Horak et al22 reported that the 3 individuals with PD scored lower (50%) on section IV (Postural Responses) than on other sections of the test (71%-78%). This was not true of the present large sample of individuals with PD (n = 80), as section IV (68%) was not lower on average than other sections. As such, one section of the BESTest alone cannot be recommended to quantify the main balance deficit for individuals with PD. It is unknown whether the sections of the BESTest could be used to guide treatment on an individual basis, as different sections may or may not indicate specific balance impairments an individual.
Mini-BEST and BESTest
Both the Mini-BESTest and the BESTest had high interrater and test-retest reliability. The BESTest has been shown to be a valid measure of balance in individuals with PD.23 The Mini-BESTest was strongly correlated with the BESTest (r = 0.955), signifying that the Mini-BESTest is also an appropriate measure of balance for individuals with PD.
When the BESTest was shortened to create the Mini-BESTest, no items from section I or II were included. Section I of the BESTest includes items assessing foot deformities, center-of-mass alignment, ankle and hip range and strength, and a floor to stand transfer. Section II includes functional reach forward, functional reach laterally, and ability to lean and return to vertical while in sitting. According to Franchignoni et al,24 the items in these sections did not truly measure dynamic balance and were therefore removed. The improved unidimensionality of the Mini-BESTest compared with the BESTest is supported by the increased difference between average scores of fallers and nonfallers, 27% difference for the Mini-BESTest versus 19% for the BESTest. Also, BESTest sections I and II had the lowest interrater reliability and section II had the least variability and smallest difference between fallers and nonfallers. Removal of these sections seemed to have improved the Mini-BESTest for individuals with PD, while decreasing the time to perform the test to 10 to 15 minutes.
The Mini-BESTest has components of multiple individual balance assessments including items from the Berg Balance Scale,33 the Dynamic Gait Index,34 single-limb stance test, functional reach,35 Timed Up and Go,36 and modified Clinical Test of Sensory Interaction on Balance37 as well as a dual-task item and postural response items. Since balance is a complex construct to measure and those with PD have multiple systems affected, studies have suggested the use of a combination of existing balance assessments to accurately identify those at risk for falls.12,38,39 Since the Mini-BESTest has been created as a combination of tests, it might allow one score to be used as opposed to having multiple separate scores for independent tests. Future work comparing the Mini-BESTest with a battery of other tests may be warranted.
Many studies have found, as in this study, that increased disease severity based on the H&Y scale is related to increased risk of falling, yet the H&Y scale has not been found to adequately predict falls and is not sensitive to smaller changes in balance due to having only 5 categories.8,12,14 The Berg Balance Scale, which is similar in time requirement to the Mini-BESTest, is commonly used for individuals with PD, yet it has been shown to have a ceiling effect.17,23,40 Based on the present study, this ceiling effect does not seem to be present in the Mini-BESTest.
Clinical Utility of Balance Assessment Tools
It is important that, when assessing fall risk, the balance measure provides more information posttest than was available pretest, and that it is capable of accurately identifying those at increased risk for falls.29 The overall accuracy of the Mini-BESTest was similar to that of the BESTest as demonstrated by a similar area under the curve. Sensitivity and specificity are both measures of correct identification (as a faller or nonfaller) when using a specific cutoff score. The preferred cutoff values for the Mini-BESTest and BESTest, chosen by minimizing both false positives and false negatives, were 20/32 (63%) and 69%, respectively. Cutoff scores maximizing sensitivity and decreasing LR− are also reported for comparison with other literature; however, this method greatly decreases specificity, thereby increasing the false-positive rate or rate of people who are falsely identified as fallers.
A cutoff score is not a score above which no one falls and below which everyone falls; it indicates only the level of balance impairment that is associated with falling. As balance deficits increase, balance scores decrease, and there is a progressively increasing risk for falling. The pretest probability and posttest probabilities, which can be calculated using likelihood ratios (Table 4), are useful to allow the clinician to understand the risk of falling for the individual after performing the assessment. When an individual scores 20/32 on the Mini-BESTest (LR+ = 4.03), for example, the probability of that individual being a faller is 65% (65 of 100 individuals identified as at risk will be a faller). When an individual scores above a 20/32, which is considered less risk of being a faller (LR− = 0.15), there is a 7% chance that the individual will be a faller. This can be compared to the pretest probability of being a faller, which was 31% in this sample. The result of this test, either positive (≤cutoff score) or negative (>cutoff score), could impact a clinician's decision about the need for treatment. When the cutoff scores were chosen by maximizing sensitivity, the posttest probabilities were much less informative, with a positive test showing little change in the actual probability of an individual being a faller (Table 4). The cutoff scores for the Mini-BESTest, by maximizing both sensitivity and specificity, allowed for comparable-to-slightly better LRs and posttest probabilities than the BESTest.
To further establish the Mini-BESTest as a useful balance outcome measure, future studies should evaluate these cutoff scores prospectively to see whether these balance tests are predictive of the occurrence of falls. Future studies should also assess the sensitivity of the Mini-BESTest to clinically significant changes in dynamic balance across time.
One limitation of the study is that the Mini-BESTest was not performed separately because of time constraints. The grading criteria were used for the Mini-BESTest as the participant performed the full BESTest. Since the scores from the Mini-BESTest and the BESTest were from the same 80 individuals during the same instance of testing, future studies are necessary to evaluate the Mini-BESTest when performed completely separate to fully validate the Mini-BESTest. Another factor that might affect generalizability of these results to clinical use was the administration of the evaluation by only 1 rater while the other raters concurrently observed. Although the tests are standardized, the effect of a single administrator of the assessment is unknown. The raters were blinded only to fall status during testing, not disease severity, which might have allowed some bias during testing. There were also slight alterations to sections IV and V. Although we were hesitant to alter the sections, the raters felt that it was necessary to allow 2 trials in section IV so the participant would adequately lean and perform the test as intended. Section V utilized only 1 trial of each item because of time constraints. This alteration potentially alters the psychometric properties reported by Horak et al.22 A retrospective fall report was also utilized, which offers the possibility of recall bias. Also, no definition of a fall was specified, so individuals may have had different criteria of what constituted a fall when giving their fall report. The risk of selection bias is slightly increased as 8 individuals were recruited through means other than the electronic database (word of mouth/PD organizations). Since this is a small portion of the total sample, the effect is likely small. Finally, a statistical limitation should be noted when interpreting ICCs. Having increased variability in the study population increases the ICC.31 Conversely, less variability, as seen in section II of the BESTest, can explain a lower ICC value.
There was a significant difference in all sections of the BESTest between fallers and nonfallers. However, there was no specific section of the BESTest that captured the primary balance deficit for individuals with PD. Although the Mini-BESTest has fewer than half of the items in the BESTest and takes only 15 minutes to complete, it is as reliable and has comparable-to-slightly increased discriminative properties to identify fallers.
We thank the participants for their time and effort. Thanks to Ryan Duncan, Josh Funk, John Michael Rotello, and Vanessa Heil-Chapdelaine for help with data collection and maintenance. Thanks to Fay Horak for providing the BESTest training video and Mini-BESTest. The conduct of this study was made possible by the Davis Phinney Foundation and grant UL1 RR024992 and Sub-Award Number TL1 RR024995 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research. Additional support was provided by the Greater St. Louis Chapter of the American Parkinson Disease Association (APDA) and the APDA Center for Advanced PD Research at Washington University. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of the Davis Phinney Foundation, NCRR, NIH, or the APDA.
1. Melton LJ III, Leibson CL, Achenbach SJ, et al. Fracture risk after the diagnosis of Parkinson's disease: influence of concomitant dementia. Mov Disord. 2006;21(9):1361–1367.
2. Bloem BR, Grimbergen YA, Cramer M, Willemsen M, Zwinderman AH. Prospective assessment of falls in Parkinson's disease. J Neurol. 2001;248(11):950–958.
3. Benatru I, Vaugoyeau M, Azulay JP. Postural disorders in Parkinson's disease. Neurophysiol Clin. 2008;38(6):459–465.
4. Boonstra TA, Van Der Kooij H, Munneke M, Bloem BR. Gait disorders and balance disturbances in Parkinson's disease: clinical update and pathophysiology. Curr Opin Neurol. 2008;21(4):461–471.
5. Ashburn A, Stack E, Ballinger C, Fazakarley L, Fitton C. The circumstances of falls among people with Parkinson's disease and the use of Falls Diaries to facilitate reporting. Disabil Rehabil. 2008;30(16):1205–1212.
6. Muslimovic D, Post B, Speelman JD, Schmand B, de Haan RJ. CARPA Study Group. Determinants of disability and quality of life in mild to moderate Parkinson disease. Neurology. 2008;70(23):2241–2247.
7. Mak MK, Pang MY. Parkinsonian single fallers versus recurrent fallers: different fall characteristics and clinical features. J Neurol. 2010;257(9):1543–1551.
8. Wood BH, Bilclough JA, Bowron A, Walker RW. Incidence and prediction of falls in Parkinson's disease: a prospective multidisciplinary study. J Neurol Neurosurg Psychiatry. 2002;72(6):721–725.
9. Allcock LM, Rowan EN, Steen IN, Wesnes K, Kenny RA, Burn DJ. Impaired attention predicts falling in Parkinson's disease. Parkinsonism Relat Disord. 2009;15(2):110–115.
10. Dibble LE, Addison O, Papa E. The effects of exercise on balance in persons with Parkinson's disease: a systematic review across the disability spectrum. J Neurol Phys Ther. 2009;33(1):14–26.
11. Landers MR, Backlund A, Davenport J, Fortune J, Schuerman S, Altenburger P. Postural instability in idiopathic Parkinson's disease: discriminating fallers from nonfallers based on standardized clinical measures. J Neurol Phys Ther. 2008;32(2):56–61.
12. Mak MK, Pang MY. Fear of falling is independently associated with recurrent falls in patients with Parkinson's disease: a 1-year prospective study. J Neurol. 2009;256(10):1689–1695.
13. Mak MK, Pang MY. Balance confidence and functional mobility are independently associated with falls in people with Parkinson's disease. J Neurol. 2009;256(5):742–749.
14. Pickering RM, Grimbergen YA, Rigney U, et al. A meta-analysis of six prospective studies of falling in Parkinson's disease. Mov Disord. 2007;22(13):1892–1900.
15. Ashburn A, Fazakarley L, Ballinger C, Pickering R, McLellan LD, Fitton C. A randomised controlled trial of a home based exercise programme to reduce the risk of falling among people with Parkinson's disease. J Neurol Neurosurg Psychiatry. 2007;78(7):678–684.
16. Dibble LE, Lange M. Predicting falls in individuals with Parkinson disease: a reconsideration of clinical balance measures. J Neurol Phys Ther. 2006;30(2):60–67.
17. Steffen T, Seney M. Test-retest reliability and minimal detectable change on balance and ambulation tests: the 36-item short-form health. Phys Ther. 2008;88(6):733–746.
18. Franzén E, Paquette C, Gurfinkel VS, Cordo PJ, Nutt JG, Horak FB. Reduced performance in balance, walking and turning tasks is associated with increased neck tone in Parkinson's disease. Exp Neurol. 2009;219(2):430–438.
19. Ashburn A, Stack E, Pickering RM, Ward CD. Predicting fallers in a community-based sample of people with Parkinson's disease. Gerontology. 2001;47(5):277–281.
20. Balash Y, Peretz C, Leibovich G, Herman T, Hausdorff JM, Giladi N. Falls in outpatients with Parkinson's disease: frequency, impact and identifying factors. J Neurol. 2005;252(11):1310–1315.
21. Kerr GK, Worringham CJ, Cole MH, Lacherez PF, Wood JM, Silburn PA. Predictors of future falls in Parkinson disease. Neurology. 2010;75(2):116–124.
22. Horak FB, Wrisley DM, Frank J. The Balance Evaluation Systems Test (BESTest) to differentiate balance deficits. Phys Ther. 2009;89(5):484–498.
23. Leddy AL, Crowner BE, Earhart GM. Functional gait assessment and balance evaluation system test: reliability, validity, sensitivity, and specificity for identifying individuals with Parkinson disease who fall. Phys Ther. 2011;91(1):102–113.
24. Franchignoni F, Horak F, Godi M, Nardone A, Giordano A. Using psychometric techniques to improve the Balance Evaluation Systems Test: the mini-BESTest. J Rehabil Med. 2010;42(4):323–331.
25. Goetz CG, Tilley BC, Shaftman SR, et al. Movement Disorder Society–sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008;23(15):2129–2170.
26. Goetz CG, Poewe W, Rascol O, et al. Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations. Mov Disord. 2004;19(9):1020–1028.
28. Akobeng AK. Understanding diagnostic tests 2: likelihood ratios, pre- and post-test probabilities and their use in clinical practice. Acta Paediatr. 2007;96(4):487–491.
29. Deeks JJ. Using evaluations of diagnostic tests: understanding their limitations and making the most of available evidence. Ann Oncol. 1999;10(7):761–768.
30. Morris ME, Martin CL, Schenkman ML. Striding out with Parkinson disease: evidence-based Physical Therapy for gait disorders. Phys Ther. 2010;90(2):280–288.
31. Weir JP Quantifying test-retest reliability using the intraclass correlation coefficient and the SEM. J Strength Cond Res. 2005;19(1):231–240.
32. Robinson K, Dennison A, Roalf D, et al. Falling risk factors in Parkinson's disease. Neuro Rehabil. 2005;20(3):169–182.
33. Berg KO, Wood-Dauphinee SL, Williams JI, Maki B. Measuring balance in the elderly: validation of an instrument. Can J Public Health. 1992;83(Suppl 2):S7–S11.
34. Wrisley DM, Walker ML, Echternach JL, Strasnick B. Reliability of the dynamic gait index in people with vestibular disorders. Arch Phys Med Rehabil. 2003;84(10):1528–1533.
35. Duncan PW, Weiner DK, Chandler J, Studenski S. Functional reach: a new clinical measure of balance. J Gerontol. 1990;45(6):M192-M197.
36. Podsiadlo D, Richardson S. The Timed “Up & Go”: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991;39(2):142–148.
37. Shumway-Cook A, Horak FB. Assessing the influence of sensory interaction of balance. Suggestion from the field. Phys Ther. 1986;66(10):1548–1550.
38. Lim LI, van Wegen EE, de Goede CJ, et al. Measuring gait and gait-related activities in Parkinson's patients own home environment: a reliability, responsiveness and feasibility study. Parkinsonism Relat Disord. 2005;11(1):19–24.
39. Dibble LE, Christensen J, Ballard DJ, Foreman KB. Diagnosis of fall risk in Parkinson disease: an analysis of individual and collective clinical balance test interpretation. Phys Ther. 2008;88(3):323–332.
40. Tanji H, Gruber-Baldini AL, Anderson KE, et al. A comparative study of physical performance measures in Parkinson's disease. Mov Disord. 2008;23(13):1897–1905.
balance; balance assessment; BESTest; fall risk; Mini-BESTest; Parkinson disease; reliability© 2011 Neurology Section, APTA